0001209191-23-038885.txt : 20230621
0001209191-23-038885.hdr.sgml : 20230621
20230621181706
ACCESSION NUMBER: 0001209191-23-038885
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230619
FILED AS OF DATE: 20230621
DATE AS OF CHANGE: 20230621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harris Erik
CENTRAL INDEX KEY: 0001780113
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36276
FILM NUMBER: 231031079
MAIL ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc.
CENTRAL INDEX KEY: 0001515673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272546083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 415-483-8800
MAIL ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-19
0
0001515673
Ultragenyx Pharmaceutical Inc.
RARE
0001780113
Harris Erik
60 LEVERONI COURT
NOVATO
CA
94949
0
1
0
0
EVP & Chief Commercial Officer
0
Common Stock
2023-06-19
4
S
0
305
48.20
D
57281
D
Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").
Includes 242 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2023.
Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
/s/ Karah Parschauer, attorney-in-fact
2023-06-21